News By Tag
* Drug Development
* Mathematical Modeling
* More Tags...
News By Place
Dr. Toufigh Gordi to discuss the Selection of Appropriate Modeling Techniques in Drug Development
Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process at 4th World PK/PD Summit on November 28, 2012 in Frankfort, Germany
“Understanding and applying the best model and the most appropriate use of mathematical modeling can add significant value to the drug development process,” said Dr. Ron Beaver, Rosa’s President and CEO.
“Quantitative analysis of the available data and systems models based on the best available knowledge can significantly increase our understanding of the observations and the underlying mechanism. Such an approach has the potential to radically improve the drug development process,” said Dr. Toufigh Gordi, Rosa’s President of PK/PD and Clinical Pharmacology Services.
Rosa informs our customer’s most critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of related issues, Rosa offers two customized approaches: classic pharmacokinetic/
More information can be found online at http://www.rosaandco.com
Rosa and the Rosa logo are registered trademarks of Rosa & Co. LLC.